Clinical Trial Update: Toripalimab ± Chemo as Neoadjuvant Therapy in LA-HNSCC: A Phase III Trial [Phase 3]

View source ↗

Summary

A Phase III clinical trial is planned to evaluate toripalimab with or without chemotherapy as neoadjuvant therapy for locally advanced head and neck squamous ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Head and Neck Squamous Cell Carcinoma HNSCC | Phase 3 | Status: NOT_YET_RECRUITING